ArticleJournal of racial and ethnic health disparities2026
Comparison of Black and/or Hispanic Cancer Patients' Experiences in Virtual Tobacco Treatment.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionLow engagement with tobacco treatment by Black and/or Hispanic adults with cancer who smoke may perpetuate health disparities. The current secondary analysis of a tobacco treatment trial aimed to describe the racial and ethnic characteristics of Black and/or Hispanic cancer patients and to examine the association between these characteristics and treatment outcomes.
methodEligibility criteria were: 18 + years old, newly diagnosed with cancer, smoked ≥ 1 cigarette in the past month, and spoke English or Spanish. Participants who self-identified as Black and/or Hispanic (N = 41), or White (N = 255) received (1) four telephone counseling sessions and information about smoking cessation medication or (2) eight telephone counseling sessions and 3 monthly booster sessions plus 12 weeks of free smoking cessation medication. We examined sociodemographic characteristics, smoking history, and cultural characteristics (e.g., racial/ethnic identity, language, familism, religiosity) at baseline and smoking abstinence at 3- and 6-month follow-ups.
resultsBlack and/or Hispanic patients smoked fewer cigarettes per day (10.5 vs. 14.7 cigarettes per day, p = .03) and reported higher levels of baseline quitting self-efficacy compared to White patients (6.5 vs. 5.3, p = .006). Black and/or Hispanic patients had similar treatment engagement, protocol adherence, and biochemically confirmed smoking abstinence at 3- and 6-month follow-ups compared to White non-Hispanic patients, controlling for the treatment group. DISCUSSION: Findings suggest that virtual tobacco treatment was accessible and effective for Black and/or Hispanic cancer patients. Tailored treatment may support greater benefits from tobacco treatment among Black and/or Hispanic patients who experience a greater health burden associated with smoking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.